CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,323 | $4,339 | $4,615 | $6,837 |
| - Cash | $159 | $155 | $182 | $149 |
| + Debt | $27 | $30 | $23 | $27 |
| Enterprise Value | $4,192 | $4,214 | $4,455 | $6,714 |
| Revenue | $176 | $191 | $195 | $187 |
| % Growth | -8.2% | -1.8% | 4.3% | – |
| Gross Profit | $121 | $130 | $137 | $129 |
| % Margin | 69.1% | 67.7% | 70.4% | 69.2% |
| EBITDA | $40 | $52 | $58 | $64 |
| % Margin | 22.6% | 27.2% | 29.6% | 34.2% |
| Net Income | $31 | $38 | $42 | $41 |
| % Margin | 17.8% | 19.7% | 21.3% | 21.9% |
| EPS Diluted | 1.31 | 1.58 | 1.74 | 1.72 |
| % Growth | -17.1% | -9.2% | 1.2% | – |
| Operating Cash Flow | $30 | $58 | $61 | $46 |
| Capital Expenditures | -$22 | -$25 | -$21 | -$25 |
| Free Cash Flow | $7 | $33 | $40 | $21 |